Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Two key policy goals in the health sector are equity and financial protection. New methods, data and powerful computers have led to a surge of interest in quantitative analysis that permits monitoring progress toward these objectives, and comparisons across countries. ADePT is a new computer program that streamlines and automates such work, ensuring that results are genuinely comparable and allowing them to be produced with a minimum of programming skills. This book provides a step-by-step guide to the use of ADePT for quantitative analysis of equity and financial protection in the health sect
Medical economics --- Data processing. --- Statistical methods. --- ADEPT. --- Economics, Medical --- Health --- Health economics --- Hygiene --- Medical care --- Medicine --- Economic aspects --- ADEPT (Computer program) --- A Distinctly empirical prover of theorems (Computer program)
Choose an application
"Simulating Distributional Impacts of Macro-dynamics: Theory and Practical Applications is a comprehensive guide for analyzing and understanding the effects of macroeconomic shocks on income and consumption distribution, as well as for using the ADePT Simulation Module. Since real-time micro data is rarely available, the Simulation Module (part of the ADePT economic analysis software) takes advantage of historical household surveys to estimate how current or proposed macro changes might impact household and individual welfare"--Back cover.
Consumption. --- Economics. --- Macroeconomics. --- Income distribution --- Business cycles --- Macroeconomics --- Well-being --- Economics --- Business & Economics --- Economic Theory --- Computer simulation --- Economic aspects --- Computer programs --- Simulation methods --- Mathematical models. --- ADePT simulation module.
Choose an application
Since the end of the Second World War, the international community has been focusing on reducing the number and the proportion of people who suffer from hunger. Over time it became clear that no single indicator would provide a comprehensive picture of the food security situation. Rather, a suite of indicators is necessary to describe food insecurity in all its dimensions. The demand for evidence-based policies, which brings together providers such as statistical offices and users of food security indicators including policy makers and researchers, has also been increasing.
Food --- Safety measures. --- ADEPT (Computer program) --- Food security --- Household surveys --- Computer programs. --- Research --- Data processing. --- Statistical methods. --- Food deserts --- Food insecurity --- Insecurity, Food --- Security, Food --- Human security --- Food supply --- Surveys, Household --- Surveys --- Census --- A Distinctly empirical prover of theorems (Computer program)
Choose an application
Private houses --- melancholy --- dwellings --- Denmark --- 72.039(489) --- A+U (tijdschrift) --- Vandkunsten Architects --- ADEPT --- Jeppe Utzon --- Vipp --- Primus Architects --- LETH & GORI --- KRADS --- Praksis Architects --- Friis & Moltke Architects --- E+N Architecture --- Trude Mardal --- Atelier Lise Juel --- Anders Abraham Architects --- Architectuurgeschiedenis ; 2000 - 2050 ; Denemarken --- architectuur, Denemarken
Choose an application
The word "cancer" is associated with at least 100 different pathologies, depending on the organ involved and the type of tumor developed. Cancer is a complex disease involving multiple pathogenetic mechanisms. Characterization of different types of cancers, which distinguishes them from healthy cells and other cancers, allows for the identification of specific targets for each individual tumor. The principle of chemotherapy is based on interference with the mechanisms that regulate the life and proliferation of cancer cells, causing their death. In recent years, there has been continuous progress in the development of therapeutic agents against cancer, which is ongoing.The Anticancer Inhibitors Special Issue focuses on new target-based anticancer agents that inhibit a specific target involved in the suppression of various types of cancer and the control of their chemoresistance.There is a collection of research and review articles on advances in drug discovery, design, and development of new inhibitor compounds with potency against various cancer types.
Research & information: general --- Chemistry --- breast cancer --- tamoxifen --- LY294002 --- synergism --- apoptosis --- cell cycle --- tea (Camellia sinensis) flowers --- BTFS --- A2780/CP70 ovarian cancer cells --- S phase cell cycle arrest --- nicotinamide phosphoribosyltransferase --- NAD+ biosynthesis --- inhibitor --- azacyclohexane --- anticancer drug --- drug design --- enthalpy effect --- NSCLC --- Cathepsin K --- cell proliferation --- cell migration --- cell invasion --- mTOR --- isatin-hydrazones --- cytotoxicity --- CDK2 inhibitor --- ATP competitive inhibitor --- ADME analysis --- receptor tyrosine kinases --- protein-protein interactions --- protein engineering --- directed evolution --- angiogenesis --- binding affinity --- agonistic activity --- saponins --- phytochemicals --- tea (Camellia sinensis) flower --- ovarian cancer --- autophagy --- ZMYND8 --- tumorigenesis --- epigenetic regulation --- pro-oncogenic effects --- tumor suppression --- tacrine-coumarin derivatives --- DNA --- topoisomerases I, II --- lung carcinoma cells --- A549 --- chemotherapy --- prodrug --- drug targeting --- overexpressed enzymes --- ADC --- ADEPT --- GDEPT --- LEAPT --- PROTAC --- cyclin-dependent kinase --- cancer --- resistance --- small molecule inhibitors --- PROTACs --- statins --- pancreatic cancer --- DNA microarray --- pitavastatin --- cerivastatin --- simvastatin --- fluvastatin --- atorvastatin --- pravastatin --- HMG-CoA reductase inhibitors --- n/a
Choose an application
The word "cancer" is associated with at least 100 different pathologies, depending on the organ involved and the type of tumor developed. Cancer is a complex disease involving multiple pathogenetic mechanisms. Characterization of different types of cancers, which distinguishes them from healthy cells and other cancers, allows for the identification of specific targets for each individual tumor. The principle of chemotherapy is based on interference with the mechanisms that regulate the life and proliferation of cancer cells, causing their death. In recent years, there has been continuous progress in the development of therapeutic agents against cancer, which is ongoing.The Anticancer Inhibitors Special Issue focuses on new target-based anticancer agents that inhibit a specific target involved in the suppression of various types of cancer and the control of their chemoresistance.There is a collection of research and review articles on advances in drug discovery, design, and development of new inhibitor compounds with potency against various cancer types.
breast cancer --- tamoxifen --- LY294002 --- synergism --- apoptosis --- cell cycle --- tea (Camellia sinensis) flowers --- BTFS --- A2780/CP70 ovarian cancer cells --- S phase cell cycle arrest --- nicotinamide phosphoribosyltransferase --- NAD+ biosynthesis --- inhibitor --- azacyclohexane --- anticancer drug --- drug design --- enthalpy effect --- NSCLC --- Cathepsin K --- cell proliferation --- cell migration --- cell invasion --- mTOR --- isatin-hydrazones --- cytotoxicity --- CDK2 inhibitor --- ATP competitive inhibitor --- ADME analysis --- receptor tyrosine kinases --- protein-protein interactions --- protein engineering --- directed evolution --- angiogenesis --- binding affinity --- agonistic activity --- saponins --- phytochemicals --- tea (Camellia sinensis) flower --- ovarian cancer --- autophagy --- ZMYND8 --- tumorigenesis --- epigenetic regulation --- pro-oncogenic effects --- tumor suppression --- tacrine-coumarin derivatives --- DNA --- topoisomerases I, II --- lung carcinoma cells --- A549 --- chemotherapy --- prodrug --- drug targeting --- overexpressed enzymes --- ADC --- ADEPT --- GDEPT --- LEAPT --- PROTAC --- cyclin-dependent kinase --- cancer --- resistance --- small molecule inhibitors --- PROTACs --- statins --- pancreatic cancer --- DNA microarray --- pitavastatin --- cerivastatin --- simvastatin --- fluvastatin --- atorvastatin --- pravastatin --- HMG-CoA reductase inhibitors --- n/a
Choose an application
The word "cancer" is associated with at least 100 different pathologies, depending on the organ involved and the type of tumor developed. Cancer is a complex disease involving multiple pathogenetic mechanisms. Characterization of different types of cancers, which distinguishes them from healthy cells and other cancers, allows for the identification of specific targets for each individual tumor. The principle of chemotherapy is based on interference with the mechanisms that regulate the life and proliferation of cancer cells, causing their death. In recent years, there has been continuous progress in the development of therapeutic agents against cancer, which is ongoing.The Anticancer Inhibitors Special Issue focuses on new target-based anticancer agents that inhibit a specific target involved in the suppression of various types of cancer and the control of their chemoresistance.There is a collection of research and review articles on advances in drug discovery, design, and development of new inhibitor compounds with potency against various cancer types.
Research & information: general --- Chemistry --- breast cancer --- tamoxifen --- LY294002 --- synergism --- apoptosis --- cell cycle --- tea (Camellia sinensis) flowers --- BTFS --- A2780/CP70 ovarian cancer cells --- S phase cell cycle arrest --- nicotinamide phosphoribosyltransferase --- NAD+ biosynthesis --- inhibitor --- azacyclohexane --- anticancer drug --- drug design --- enthalpy effect --- NSCLC --- Cathepsin K --- cell proliferation --- cell migration --- cell invasion --- mTOR --- isatin-hydrazones --- cytotoxicity --- CDK2 inhibitor --- ATP competitive inhibitor --- ADME analysis --- receptor tyrosine kinases --- protein-protein interactions --- protein engineering --- directed evolution --- angiogenesis --- binding affinity --- agonistic activity --- saponins --- phytochemicals --- tea (Camellia sinensis) flower --- ovarian cancer --- autophagy --- ZMYND8 --- tumorigenesis --- epigenetic regulation --- pro-oncogenic effects --- tumor suppression --- tacrine-coumarin derivatives --- DNA --- topoisomerases I, II --- lung carcinoma cells --- A549 --- chemotherapy --- prodrug --- drug targeting --- overexpressed enzymes --- ADC --- ADEPT --- GDEPT --- LEAPT --- PROTAC --- cyclin-dependent kinase --- cancer --- resistance --- small molecule inhibitors --- PROTACs --- statins --- pancreatic cancer --- DNA microarray --- pitavastatin --- cerivastatin --- simvastatin --- fluvastatin --- atorvastatin --- pravastatin --- HMG-CoA reductase inhibitors --- breast cancer --- tamoxifen --- LY294002 --- synergism --- apoptosis --- cell cycle --- tea (Camellia sinensis) flowers --- BTFS --- A2780/CP70 ovarian cancer cells --- S phase cell cycle arrest --- nicotinamide phosphoribosyltransferase --- NAD+ biosynthesis --- inhibitor --- azacyclohexane --- anticancer drug --- drug design --- enthalpy effect --- NSCLC --- Cathepsin K --- cell proliferation --- cell migration --- cell invasion --- mTOR --- isatin-hydrazones --- cytotoxicity --- CDK2 inhibitor --- ATP competitive inhibitor --- ADME analysis --- receptor tyrosine kinases --- protein-protein interactions --- protein engineering --- directed evolution --- angiogenesis --- binding affinity --- agonistic activity --- saponins --- phytochemicals --- tea (Camellia sinensis) flower --- ovarian cancer --- autophagy --- ZMYND8 --- tumorigenesis --- epigenetic regulation --- pro-oncogenic effects --- tumor suppression --- tacrine-coumarin derivatives --- DNA --- topoisomerases I, II --- lung carcinoma cells --- A549 --- chemotherapy --- prodrug --- drug targeting --- overexpressed enzymes --- ADC --- ADEPT --- GDEPT --- LEAPT --- PROTAC --- cyclin-dependent kinase --- cancer --- resistance --- small molecule inhibitors --- PROTACs --- statins --- pancreatic cancer --- DNA microarray --- pitavastatin --- cerivastatin --- simvastatin --- fluvastatin --- atorvastatin --- pravastatin --- HMG-CoA reductase inhibitors
Choose an application
"When Isaac Newton’s alchemical papers surfaced at a Sotheby’s auction in 1936, the quantity and seeming incoherence of the manuscripts were shocking. No longer the exemplar of Enlightenment rationality, the legendary physicist suddenly became “the last of the magicians.” Newton the Alchemist unlocks the secrets of Newton’s alchemical quest, providing a radically new understanding of the uncommon genius who probed nature at its deepest levels in pursuit of empirical knowledge. In this evocative and superbly written book, William Newman blends in-depth analysis of newly available texts with laboratory replications of Newton’s actual experiments in alchemy. He does not justify Newton’s alchemical research as part of a religious search for God in the physical world, nor does he argue that Newton studied alchemy to learn about gravitational attraction. Newman traces the evolution of Newton’s alchemical ideas and practices over a span of more than three decades, showing how they proved fruitful in diverse scientific fields. A precise experimenter in the realm of “chymistry,” Newton put the riddles of alchemy to the test in his lab. He also used ideas drawn from the alchemical texts to great effect in his optical experimentation. In his hands, alchemy was a tool for attaining the material benefits associated with the philosopher’s stone and an instrument for acquiring scientific knowledge of the most sophisticated kind. Newton the Alchemist provides rare insights into a man who was neither Enlightenment rationalist nor irrational magus, but rather an alchemist who sought through experiment and empiricism to alter nature at its very heart." -- Publisher's description.
Alchemy --- Metals, Transmutation of --- Philosophers' egg --- Philosophers' stone --- Stone, Philosophers' --- Transmutation of metals --- Chemistry --- Occultism --- History --- Newton, Isaac, --- Newton, Izaak, --- Niu-tun, --- Nʹi︠u︡ton, Isaak, --- Niutun, Yisake, --- Niyu̇ton, Isak, --- Nyuṭon, Ayzaḳ, --- Nyuṭon, Ayziḳ, --- ניוטאן, אייזאק, --- ניוטון, אייזק --- ניוטון, אייזיק --- 牛頓, --- 牛頓, 伊萨克, --- Knowledge --- Alchemy. --- Benedictine Basilius Valentinus. --- CU Add. 3973. --- Captain Hylliard. --- Eirenaeus Philalethes. --- Enlightenment. --- Epistola ad Theodorum Mundanum. --- Free Grammar School. --- Humores minerales. --- Hypothesis of Light. --- Isaac Newton. --- Johann de Monte-Snyders. --- Johann de Monte–Snyders. --- Keynes 35. --- Keynes 58. --- Keynes MS 58. --- Michael Sendivogius. --- Nicolas Fatio de Duillier. --- Nicolas Flamel. --- Of Natures obvious laws & processes in vegetation. --- Opera. --- Opticks. --- Philalethes. --- Praxis. --- Ramon Lull. --- Robert Boyle. --- Sendivogius. --- Three Mysterious Fires. --- Treatise of Chymistry. --- Trinity College. --- William Yworth. --- adept. --- alchemical text. --- alchemist. --- alchemists. --- alchemy. --- ancient mythology. --- antimonial sublimate. --- antimony. --- aurific art. --- biblical prophecy. --- caduceus of Mercury. --- chrysopoeia. --- chymical laboratory. --- chymical research. --- chymical studies. --- chymist. --- chymistry of light. --- chymistry. --- color theory. --- color. --- copper vitriol. --- education. --- empiricism. --- exegesis. --- experimental notebooks. --- experimental philosophy. --- florilegium style. --- florilegium. --- gold. --- laboratory notebooks. --- lead. --- lorilegia. --- metals. --- mining. --- natural world. --- nature. --- niter. --- optical experimentation. --- optical research. --- optics. --- our Venus. --- philosophers' stone. --- phlogiston theory. --- reason. --- refraction theory. --- refractive power. --- sal ammoniac. --- scientific collaboration. --- scientific knowledge. --- scythe of Saturn. --- sea salt. --- secret fire. --- sophic mercury. --- sophic sal ammoniac. --- sulfur. --- treatise. --- vegetability.
Listing 1 - 8 of 8 |
Sort by
|